Medicmotus - Company finances
|
EUR
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | 0 | 34,920 | 188,228 | 192,071 | 80,547 | 48,284 |
| Profit before tax | 0 | -76,086 | 33,386 | 3,430 | - | - |
| Net profit | 0 | -76,086 | 31,549 | 2,215 | -14,597 | -18,475 |
| Equity | 2,500 | -73,586 | -42,037 | -38,607 | -54,419 | -72,894 |
| Liabilities | 0 | 99,495 | 116,257 | 145,338 | 110,494 | 104,666 |
| Non-current assets | 0 | 0 | 49,146 | 87,248 | 46,696 | 28,985 |
| Current assets | 2,500 | 25,909 | 25,074 | 19,833 | 9,379 | 2,787 |
| Total assets | 2,500 | 25,909 | 74,220 | 107,081 | 56,075 | 31,772 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | 21,833 | 10,588 | 6,363 |
|
Financial indicators
|
||||||
| Revenue change y/y | - | - | +439.0% | +2.0% | -58.1% | -40.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | -293.7% | 42.5% | 2.1% | -26.0% | -58.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | -217.9% | 16.8% | 1.2% | -18.1% | -38.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | -217.9% | 17.7% | 1.8% | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 11,640 | 62,743 | 64,024 | 40,274 | 30,496 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medicmotus - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-01-21 | 2026-02-04 | 0.46 |
| 2025-10-16 | 2025-10-19 | 351.60 |
| 2024-07-24 | 2024-08-07 | 0.63 |
| 2024-04-16 | 2024-04-21 | 351.60 |
| 2023-01-02 | 2023-01-09 | 1.09 |
Medicmotus - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2024-12-16 | 2024-12-20 | 141.69 |
| 2024-10-13 | 2024-10-16 | 249.3 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medicmotus, UAB (code 304323420) is a Private Limited Liability Company engaged in intermediation service activities for medical, dental and other human health services. In 2025, the company generated revenue of €48.3K, down 40.0% year on year and 74.9% below the 2023 level of €192.1K. Profitability weakened over the period: net profit was €2.2K in 2023, then turned to a loss of €14.6K in 2024 and €18.5K in 2025, with the latest profit margin at -38.3%. The balance sheet also contracted, with total assets falling from €107.1K in 2023 to €31.8K in 2025. At the end of 2025, long-term assets stood at €29.0K and short-term assets at €2.8K. Equity remained negative and declined to -€72.9K, while liabilities were €104.7K. Revenue per employee in 2025 was €48.3K, and asset turnover was 1.52x. Overall, the latest financial year shows lower turnover, continued losses, and a weaker capital position compared with the prior two years.